Diabetes: Clinical Trials

3,038 trials for Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2161 completed, 340 unknown, 164 recruiting, 121 terminated. 1252 Not applicable, 331 Phase 1, 299 Phase 3, 239 Phase 4, 164 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1252Completed 832, Unknown 160, Recruiting 89, Terminated 51, Active not recruiting 40, Not yet recruiting 40, Withdrawn 25, Enrolling by invitation 11, Suspended 4
Phase 1331Completed 301, Unknown 11, Terminated 8, Active not recruiting 4, Recruiting 3, Withdrawn 2, Not yet recruiting 1, Suspended 1
Phase 3299Completed 249, Terminated 22, Unknown 13, Active not recruiting 6, Withdrawn 5, Recruiting 3, Not yet recruiting 1
Phase 4239Completed 178, Unknown 24, Terminated 13, Withdrawn 10, Recruiting 8, Not yet recruiting 3, Enrolling by invitation 2, Active not recruiting 1
Phase 2164Completed 116, Terminated 14, Unknown 11, Withdrawn 11, Recruiting 5, Not yet recruiting 4, Active not recruiting 3
Early Phase 120Completed 13, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Diabetes: new trials by email Literature Review of Diabetes trials Research Report on Diabetes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Na-Phenylbutyrate VAscular Trial
Sodium Phenylbutyrate, Placebo - Diabetes
Early Phase 1Not yet recruitingUniversity of Pennsylvania302027-06-012026-07-28
Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Integrated Digital Health (IDH) platform, Provider engagement - Diabetes, Diabetes Type 2
Not applicableNot yet recruitingYale University3002027-03-012026-09-29
Continuous Glucose Monitoring for In-hospital Management of Type 2 Diabetes
Continuous glucose monitoring - Diabetes, Continuous Glucose Monitoring System
Not applicableNot yet recruitingSteno Diabetes Center Copenhagen3142027-03-012026-09-01
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION, Sham percutaneous electrical nerve field stimulation - Diabetes, Gastroparesis
Not applicableNot yet recruitingIndiana University602027-02-102026-10-01
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
Culturally-tailored, enhanced adaption of Diabetes Prevention Program - Diabetes, Physical Activity
Not applicableNot yet recruitingUniversity of Missouri, Kansas City4082027-01-042026-06-09
Creating Linked Inpatient CGM for Kids
Diabetes, Continuous Glucose Monitoring System
Not yet recruitingBoston Children's Hospital202027-01-012026-04-03
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
pulsENDO Therapy - Diabetes Type 2, Diabetes
Not applicableNot yet recruitingEndogenex, Inc.3202027-01-012026-08-18
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation
Gut motility quantification using a capsule after initiating GLP-1RA therapy - Diabetes
Not applicableNot yet recruitingThe Cleveland Clinic202026-12-012026-08-25
Pharmacogenetics of Response to Sitagliptin (PRS)
Oral Glucose Tolerance Test - Diabetes
Phase 4Not yet recruitingUniversity of Maryland, Baltimore4002026-12-012026-02-18
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
Continuous Glucose Monitoring (CGM) - End Stage Kidney Disease (ESKD), Hyperglycaemia
Not yet recruitingEmory University1802026-12-012026-10-19
PNS to Improve Vascular Function and Limb Health in Veterans
Chronically Implanted Neural and Muscular Interface, Peripheral Nerve Stimulation (PNS) - Lower Limb Amputees, Diabetes
Not applicableNot yet recruitingVA Office of Research and Development422026-11-022026-08-21
Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition
Dexcom G7 CGM - Diabetes
Not applicableNot yet recruitingUniversity of Nebraska802026-10-302026-10-19
Effects of Meal Macronutrients on Postprandial Lipids
High carb then high fat breakfast, High fat then high carb breakfast - Nephrotic Syndrome, Lipodystrophy
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1002026-10-262026-10-21
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
Obesity, Diabetes
Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)10002026-10-262026-10-21
Genetically Informed Screening for Early-Stage Type 1 Diabetes
Diabetes
Not yet recruitingMassachusetts General Hospital1502026-10-152026-09-08
Using Healthcare Financing and Digital Technology to Improve Hypertension Prevention and Control in Tanzania
Nurse-delivered care using WelTel check-ins and BCC SMS, Community-based peer-support model - Hypertension, Diabetes
Not applicableNot yet recruitingDr. Karen Yeates13202026-10-012026-08-24
Rowing and Cycling Reduce Inflammation in Early-Stage Type 2 Diabetes
Continuous Exercise - Cycling Group, Rowing Ergometer High-Intensity Interval Training, Combined Training Standard - Diabetes
Not applicableNot yet recruitingThe 95th Hospital of Putian,Putian, Fujian, China1202026-10-012026-08-18
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
Epalrestat, Donafenib + Tislelizumab, HAIC - HCC - Hepatocellular Carcinoma, Diabetes
Phase 2Not yet recruitingHaibo Shao322026-10-012026-09-21
Effectiveness of Personalized Oral Hygiene Advice Delivered by Artificial Intelligence or Dental Professionals Versus Standard Oral Hygiene Advice on Oral and Systemic Health in Community-based Type II Diabetes Patients
AI OHI group, Human-OHI group, Control group - Gum Disease, Diabetes
Not applicableNot yet recruitingThe University of Hong Kong1052026-10-012026-10-01

Showing 20 of 3038. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus (3038)  ·  Diabetes Mellitus, Type 2 (593)  ·  Obesity (355)  ·  Hypertension (344)  ·  Diabetes Mellitus, Type 1 (272)  ·  Cardiovascular Diseases (180)  ·  Insulin Resistance (137)  ·  Metabolic Syndrome (96)  ·  Motor Activity (81)  ·  Glucose Intolerance (75)  ·  Overweight (74)  ·  Dyslipidemias (73)  ·  Heart Failure (66)  ·  Neoplasms (64)  ·  Depression (63)

Broader conditions

Nutritional and Metabolic Diseases (3037)  ·  Endocrine System Diseases (3028)  ·  Glucose Metabolism Disorders (3028)  ·  Metabolic Diseases (3004)  ·  Pathological Conditions, Signs and Symptoms (699)  ·  Vascular Diseases (521)  ·  Cardiovascular Diseases (513)  ·  Signs and Symptoms (490)  ·  Nutrition Disorders (391)  ·  Body Weight (381)  ·  Overnutrition (381)  ·  Immune System Diseases (334)  ·  Overweight (307)  ·  Pathologic Processes (299)  ·  Autoimmune Diseases (287)

Interventions

Insulin Aspart (149)  ·  Insulin Detemir (123)  ·  insulin aspart, insulin aspart protamine drug combination 30:70 (112)  ·  Liraglutide (97)  ·  Insulin Glargine (90)  ·  Metformin (86)  ·  insulin degludec (85)  ·  semaglutide (67)  ·  Insulin, Isophane (49)  ·  Insulin (44)  ·  Exercise (38)  ·  insulin degludec, insulin aspart drug combination (35)  ·  Sitagliptin Phosphate (25)  ·  repaglinide (24)  ·  Continuous Glucose Monitoring (23)

Sponsors

Novo Nordisk A/S (635)  ·  Emory University (33)  ·  Ascensia Diabetes Care (30)  ·  University of Toronto (29)  ·  University of Pennsylvania (28)  ·  Brigham and Women's Hospital (26)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (26)  ·  VA Office of Research and Development (24)  ·  US Department of Veterans Affairs (23)  ·  Mayo Clinic (20)  ·  University of Colorado, Denver (18)  ·  NYU Langone Health (17)  ·  AstraZeneca (16)  ·  University of Pittsburgh (16)  ·  Washington University School of Medicine (16)

Countries

United States (1190)  ·  Germany (246)  ·  United Kingdom (199)  ·  Canada (191)  ·  China (174)  ·  France (172)  ·  Denmark (115)  ·  Italy (103)  ·  Spain (94)  ·  India (89)  ·  Japan (78)  ·  Russia (78)  ·  Israel (77)  ·  South Korea (75)  ·  Turkey (Türkiye) (75)

Top investigators

Timothy Bailey, MD (13)  ·  Guillermo Umpierrez, MD (11)  ·  Shirley Wang, PhD, ScM (9)  ·  David JA Jenkins, MD, PhD, DSc (8)  ·  John L Sievenpiper, MD, PhD (8)  ·  David Simmons, MD (7)  ·  Russell J de Souza, ScD, RD (7)  ·  Cyril WC Kendall, PhD (5)  ·  Eckhard Salzsieder, PhD (5)  ·  Juliana Chan, MD (5)  ·  Leslie J Klaff, MD (5)

Results publications

PMID 25504028, PMID 31903692, PMID 32998732, PMID 35044568, PMID 39963952, PMID 23010561, PMID 32267058, PMID 21450987, PMID 21883806, PMID 22193143, PMID 22862847, PMID 23130654, PMID 23186975, PMID 24170235, PMID 26232910, PMID 30615985, PMID 31769496, PMID 33327727, PMID 19245711, PMID 19491536, PMID 21209033, PMID 22055210, PMID 24561125, PMID 26121451, PMID 28205039, PMID 33166419, PMID 35373893, PMID 19878259, PMID 25581159, PMID 26484727, PMID 26663320, PMID 29451706, PMID 29766634, PMID 29862621, PMID 29907893, PMID 30402720, PMID 31215727, PMID 33660198, PMID 33969456, PMID 24812526, PMID 25081590, PMID 26936426, PMID 29687620, PMID 29748996, PMID 32193837, PMID 32827435, PMID 36056351, PMID 37178435, PMID 26582052, PMID 26612062

NIH funding

2009 (32), 2008 (20), 2014 (19), 2015 (19), 2005 (14), 2016 (11), 2004 (5), 2017 (5), 2019 (4), P30DK111024 (4), 2023 (3), OT2HL158287 (3), R01DK060555 (3), 2018 (2), P30AG064199 (2)